Lindsell Train LTD Has Cut Its Holding in Pepsico (PEP) by $12.10 Million as Stock Value Declined; Abbvie (ABBV) Position Has Upped by Loudon Investment Management Llc

PepsiCo, Inc. (NASDAQ:PEP) Logo

Lindsell Train Ltd decreased its stake in Pepsico Inc (PEP) by 3% based on its latest 2018Q4 regulatory filing with the SEC. Lindsell Train Ltd sold 110,000 shares as the company’s stock declined 1.97% while stock markets rallied. The institutional investor held 3.56M shares of the consumer non-durables company at the end of 2018Q4, valued at $393.44 million, down from 3.67 million at the end of the previous reported quarter. Lindsell Train Ltd who had been investing in Pepsico Inc for a number of months, seems to be less bullish one the $162.42 billion market cap company. The stock increased 0.14% or $0.16 during the last trading session, reaching $115.66. About 9.97 million shares traded or 76.09% up from the average. PepsiCo, Inc. (NYSE:PEP) has risen 7.45% since March 17, 2018 and is uptrending. It has outperformed by 3.08% the S&P500. Some Historical PEP News: 22/03/2018 – Rold Gold Fires Up Pretzels With New Flamin’ Hot Thin Crisps; 26/04/2018 – PepsiCo Sees About $9B 2018 Cash From Operating Activities; 26/04/2018 – PEPSICO CFO HUGH JOHNSTON COMMENTS ON EARNINGS CALL; 26/04/2018 – PEPSICO INC – CEO SAYS BEYOND TRADEMARK PEPSI, N.AMERICA BEVERAGES IS PERFORMING REASONABLY WELL IN THE CONTEXT OF COMPETITIVE ENVIRONMENT; 26/04/2018 – PEPSICO- CEO SAYS TEAM IS “MANIACALLY” FOCUSED ON GETTING NAB BUSINESS BACK TO TRACK IN 2H18, AND WILL SEQUENTIALLY IMPROVE EVERY QUARTER; 26/04/2018 – PEPSICO SEES 2018 ORGANIC REV GROWTH TO BE AT LEAST IN LINE WITH 2017 GROWTH RATE OF 2.3 PCT; 25/05/2018 – PepsiCo: Bare Snacks Sells Apple, Banana, Coconut Snacks, Vegetable Chips; 02/04/2018 – Cambodian farmers sue Thai sugar group Mitr Phol over alleged land grab; 16/03/2018 – PEPSICO CEO NOOYI’S 2017 TOTAL COMPENSATION ROSE 4.4% TO $31.1M; 26/04/2018 – Pepsi’s snack business has been outperforming its North American beverage business

Loudon Investment Management Llc increased its stake in Abbvie Inc (ABBV) by 36.69% based on its latest 2018Q4 regulatory filing with the SEC. Loudon Investment Management Llc bought 9,771 shares as the company’s stock declined 10.66% while stock markets rallied. The institutional investor held 36,404 shares of the major pharmaceuticals company at the end of 2018Q4, valued at $3.36 million, up from 26,633 at the end of the previous reported quarter. Loudon Investment Management Llc who had been investing in Abbvie Inc for a number of months, seems to be bullish on the $119.98 billion market cap company. The stock increased 1.74% or $1.39 during the last trading session, reaching $81.34. About 12.75M shares traded or 76.83% up from the average. AbbVie Inc. (NYSE:ABBV) has declined 30.20% since March 17, 2018 and is downtrending. It has underperformed by 34.57% the S&P500. Some Historical ABBV News: 25/04/2018 – AbbVie Submits Biologics License Application to U.S. FDA for Investigational Treatment Risankizumab for Moderate to Severe Plaq; 05/04/2018 – $ABBV $BIIB Settlement on Humira #Biosimilar in Europe -; 20/03/2018 – EXACT SCIENCES CORP – STENHOUSE, VICE PRESIDENT, U.S. IMMUNOLOGY AT ABBVIE, WILL ASSUME NEW POSITION ON APRIL 2, 2018; 30/04/2018 – Merck: FDA Grants Priority Review to sBLA for Keytruda Combination; 10/04/2018 – AbbVie: FDA Requires Extended Time for Review of Additional Info in New Drug Application; 26/04/2018 – ABBVIE INC – UPDATES 2018 GAAP SHR OUTLOOK TO $6.82-$6.92; RAISES 2018 ADJUSTED SHR OUTLOOK TO $7.66-$7.76 FROM $7.33-$7.43; 10/04/2018 – Samsung Bioepis may pay 5% of Humira biosimilar sales as royalty to AbbVie, insiders say; 25/04/2018 – ABBVIE SUBMITS BIOLOGICS LICENSE APPLICATION TO U.S. FDA FOR IN; 24/05/2018 – IMBRUVICA┬« (IBRUTINIB) PLUS GAZYVA┬« (OBINUTUZUMAB) PHASE 3; 17/04/2018 – Blood-cancer treatments Imbruvica and Darzalex have boosted J&J’s pharmaceutical sales, while rheumatoid arthritis drug Remicade has been under pressure

Investors sentiment increased to 0.83 in 2018 Q4. Its up 0.01, from 0.82 in 2018Q3. It improved, as 60 investors sold ABBV shares while 631 reduced holdings. 129 funds opened positions while 444 raised stakes. 996.27 million shares or 0.22% more from 994.12 million shares in 2018Q3 were reported. 689,556 were reported by Citigroup. Indiana Tru Inv Management owns 17,753 shares for 0.91% of their portfolio. Montrusco Bolton Invests Inc owns 5,716 shares. Baxter Bros Inc reported 0.07% of its portfolio in AbbVie Inc. (NYSE:ABBV). California-based Orbis Investment Mgmt (Us) LP has invested 12.98% in AbbVie Inc. (NYSE:ABBV). Valley Natl Advisers reported 11,459 shares stake. Hanson Mcclain stated it has 0.03% of its portfolio in AbbVie Inc. (NYSE:ABBV). Pittenger Anderson reported 10,085 shares stake. Moreover, Beck Mack & Oliver Limited Liability has 0.23% invested in AbbVie Inc. (NYSE:ABBV) for 62,097 shares. Moreover, Exane Derivatives has 0% invested in AbbVie Inc. (NYSE:ABBV). Natixis Advsr Lp reported 426,267 shares. Nbt Financial Bank N A New York accumulated 0.79% or 53,212 shares. Headinvest Limited Co accumulated 13,298 shares. Sector Pension Inv Board reported 93,935 shares or 0.07% of all its holdings. Maplelane Capital Ltd Liability Co holds 1 shares.

Loudon Investment Management Llc, which manages about $170.56 million and $105.33 million US Long portfolio, decreased its stake in Vanguard Scottsdale Fds (VCSH) by 4,085 shares to 24,879 shares, valued at $1.94 million in 2018Q4, according to the filing. It also reduced its holding in Kraft Heinz Co by 7,930 shares in the quarter, leaving it with 40,205 shares, and cut its stake in Spdr S&P 500 Etf Tr (SPY).

Since November 29, 2018, it had 0 insider buys, and 5 sales for $21.78 million activity. Another trade for 60,000 shares valued at $5.40M was made by CHASE WILLIAM J on Wednesday, December 12. Shares for $3.82M were sold by Gosebruch Henry O. 16,850 shares were sold by GONZALEZ RICHARD A, worth $1.50 million.

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Seekingalpha.com which released: “Teva settlement with FTC resolves all litigation – Seeking Alpha” on February 19, 2019, also Seekingalpha.com with their article: “FDA accepts AbbVie’s marketing application for upadacitinib for RA – Seeking Alpha” published on February 19, 2019, Seekingalpha.com published: “AbbVie, Inc. (ABBV) Presents at Barclays Global Healthcare Broker Conference Call – (Transcript) – Seeking Alpha” on March 13, 2019. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Seekingalpha.com and their article: “AbbVie Inc. (ABBV) Management Presents at Cowen Health Care Conference (Transcript) – Seeking Alpha” published on March 12, 2019 as well as Seekingalpha.com‘s news article titled: “Day of reckoning for Big Pharma – Seeking Alpha” with publication date: February 26, 2019.

Analysts await PepsiCo, Inc. (NASDAQ:PEP) to report earnings on April, 25. They expect $0.92 EPS, down 4.17% or $0.04 from last year’s $0.96 per share. PEP’s profit will be $1.29B for 31.43 P/E if the $0.92 EPS becomes a reality. After $1.49 actual EPS reported by PepsiCo, Inc. for the previous quarter, Wall Street now forecasts -38.26% negative EPS growth.

Investors sentiment increased to 0.94 in 2018 Q4. Its up 0.07, from 0.87 in 2018Q3. It increased, as 57 investors sold PEP shares while 656 reduced holdings. 142 funds opened positions while 525 raised stakes. 1.00 billion shares or 5.04% more from 952.72 million shares in 2018Q3 were reported. Whittier Trust holds 272,089 shares or 1.03% of its portfolio. 184,839 were accumulated by Twin Capital. Goldman Sachs Grp Inc accumulated 6.30M shares or 0.22% of the stock. Nomura Asset Management Limited stated it has 0.8% in PepsiCo, Inc. (NASDAQ:PEP). The Virginia-based Of Virginia Lc has invested 0.95% in PepsiCo, Inc. (NASDAQ:PEP). Evanson Asset Mgmt Ltd holds 2,031 shares or 0.05% of its portfolio. Oakbrook Llc stated it has 2.41% in PepsiCo, Inc. (NASDAQ:PEP). Tillar has invested 1.29% in PepsiCo, Inc. (NASDAQ:PEP). Congress Asset Mgmt Company Ma owns 34,354 shares. Private Harbour Inv Mngmt And Counsel Ltd Limited Liability Company has invested 1.94% of its portfolio in PepsiCo, Inc. (NASDAQ:PEP). Jpmorgan Chase & Commerce reported 14.82M shares. Moreover, Thomasville National Bank & Trust has 0.59% invested in PepsiCo, Inc. (NASDAQ:PEP). Newfocus Gru Llc holds 1.13% of its portfolio in PepsiCo, Inc. (NASDAQ:PEP) for 17,287 shares. Moreover, Alpha Windward Limited Liability Corp has 0.24% invested in PepsiCo, Inc. (NASDAQ:PEP). 122,646 were reported by Wade G W &.

Lindsell Train Ltd, which manages about $6.07B and $4.14B US Long portfolio, upped its stake in Brown Forman Corp by 140,979 shares to 1.94 million shares, valued at $91.86 million in 2018Q4, according to the filing. It also increased its holding in Manchester United Plc (NYSE:MANU) by 277,900 shares in the quarter, for a total of 10.93 million shares, and has risen its stake in Brown Forman Corp (NYSE:BF.B).

Since October 4, 2018, it had 0 buys, and 4 sales for $22.66 million activity. Shares for $18.53M were sold by Khan Mehmood on Monday, October 22. $587,364 worth of stock was sold by Narasimhan Laxman on Thursday, October 4. Spanos Mike also sold $2.26 million worth of PepsiCo, Inc. (NASDAQ:PEP) shares.

PepsiCo, Inc. (NASDAQ:PEP) Institutional Positions Chart